Mesangial proliferative glomerulonephritis: Difference between revisions
No edit summary |
No edit summary |
||
| Line 17: | Line 17: | ||
{{CMG}} | {{CMG}} | ||
==[[Mesangia overview|Overview]]== | |||
==[[Mesangial proliferative glomerulonephritis historical perspective|Historical Perspective]]== | |||
==[[Mesangial proliferative glomerulonephritis classification|Classification]]== | |||
==[[Mesangial proliferative glomerulonephritis pathophysiology|Pathophysiology]]== | |||
==[[Mesangial proliferative glomerulonephritis differential diagnosis|Differentiating Mesangial proliferative glomerulonephritis from other Diseases]]== | |||
==[[Mesangial proliferative glomerulonephritis epidemiology and demographics|Epidemiology and Demographics]]== | |||
==[[Mesangial proliferative glomerulonephritis risk factors|Risk Factors]]== | |||
==[[Mesangial proliferative glomerulonephritis screening|Screening]]== | |||
==[[Mesangial proliferative glomerulonephritis natural history|Natural History, Complications and Prognosis]]== | |||
==Diagnosis== | |||
[[Mesangial proliferative glomerulonephritis history and symptoms|History and Symptoms ]] | [[ Mesangial proliferative glomerulonephritis physical examination|Physical Examination]] | [[Mesangial proliferative glomerulonephritis laboratory findings|Laboratory Findings]] | [[Mesangial proliferative glomerulonephritis CT|CT]] | [[Mesangial proliferative glomerulonephritis MRI|MRI]] | [[Mesangial proliferative glomerulonephritis ultrasound|Ultrasound]] | [[Mesangial proliferative glomerulonephritis other imaging findings|Other Imaging Findings]] | [[Mesangial proliferative glomerulonephritis other diagnostic studies|Other Diagnostic Studies]] | |||
==Treatment== | |||
[[Mesangial proliferative glomerulonephritis medical therapy|Medical Therapy]] | [[Mesangial proliferative glomerulonephritis surgery |Surgery]] | [[Mesangial proliferative glomerulonephritis primary prevention|Primary Prevention]] | [[Mesangial proliferative glomerulonephritis secondary prevention|Secondary Prevention]] | [[Mesangial proliferative glomerulonephritis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Mesangial proliferative glomerulonephritis future or investigational therapies|Future or Investigational Therapies]] | |||
==Case Studies== | |||
[[Mesangial proliferative glomerulonephritis case study one|Case #1]] | |||
Revision as of 17:03, 27 September 2012
| Mesangial proliferative glomerulonephritis | |
| ICD-10 | N00.3-N08.3 |
|---|---|
| DiseasesDB | 31877 |
|
Mesangial proliferative glomerulonephritis Microchapters |
|
Differentiating Mesangial proliferative glomerulonephritis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Mesangial proliferative glomerulonephritis On the Web |
|
American Roentgen Ray Society Images of Mesangial proliferative glomerulonephritis |
|
Directions to Hospitals Treating Mesangial proliferative glomerulonephritis |
|
Risk calculators and risk factors for Mesangial proliferative glomerulonephritis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Pathophysiology
Differentiating Mesangial proliferative glomerulonephritis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies